Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy

Michael D. Ober, Lawrence A. Yannuzzi, Diana V. Do, Richard F. Spaide, Neil M. Bressler, Lee M. Jampol, Allison Angelilli, Chiara M. Eandi, Alice T. Lyon

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Purpose: To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC). Design: Noncomparative, nonrandomized, retrospective interventional case series. Participants: Nine eyes of 9 symptomatic patients with acute focal retinal pigment epithelial leaks secondary to CSC, confirmed with fluorescein angiography, evaluated at 1 of 3 referral retina practices. Methods: Patients were treated with photodynamic therapy using verteporfin. Best-corrected visual acuity (VA) was recorded at presentation and follow-up visits. Main Outcome Measures: Resolution of neurosensory detachment, status of fluorescein leakage, and VA. Results: Neurosensory detachment and fluorescein leakage resolved in all patients within 1 month. Visual acuity improved from 1 to 6 lines in 7 eyes and remained unchanged in 2. At 6 months, there was a statistically significant improvement in mean VA (P = 0.012, Wilcoxon signed ranks test), and mean VA improved from 20/80 to 20/40. No patient lost vision or suffered any treatment-related complications. Conclusion: The treatment of acute CSC with photodynamic therapy may result in prompt resolution of neurosensory detachment and fluorescein leakage, which can be associated with rapidly improved vision. Although this case series is limited in follow-up and number of patients, the encouraging results and lack of visually significant complications suggest that further investigation is warranted.

Original languageEnglish (US)
Pages (from-to)2088-2094
Number of pages7
JournalOphthalmology
Volume112
Issue number12
DOIs
StatePublished - Dec 1 2005

Fingerprint

Central Serous Chorioretinopathy
Retinal Pigments
Photochemotherapy
Visual Acuity
Fluorescein
Fluorescein Angiography
Nonparametric Statistics
Retina
Therapeutics
Referral and Consultation
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ober, M. D., Yannuzzi, L. A., Do, D. V., Spaide, R. F., Bressler, N. M., Jampol, L. M., ... Lyon, A. T. (2005). Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology, 112(12), 2088-2094. https://doi.org/10.1016/j.ophtha.2005.06.026

Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. / Ober, Michael D.; Yannuzzi, Lawrence A.; Do, Diana V.; Spaide, Richard F.; Bressler, Neil M.; Jampol, Lee M.; Angelilli, Allison; Eandi, Chiara M.; Lyon, Alice T.

In: Ophthalmology, Vol. 112, No. 12, 01.12.2005, p. 2088-2094.

Research output: Contribution to journalArticle

Ober, MD, Yannuzzi, LA, Do, DV, Spaide, RF, Bressler, NM, Jampol, LM, Angelilli, A, Eandi, CM & Lyon, AT 2005, 'Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy', Ophthalmology, vol. 112, no. 12, pp. 2088-2094. https://doi.org/10.1016/j.ophtha.2005.06.026
Ober, Michael D. ; Yannuzzi, Lawrence A. ; Do, Diana V. ; Spaide, Richard F. ; Bressler, Neil M. ; Jampol, Lee M. ; Angelilli, Allison ; Eandi, Chiara M. ; Lyon, Alice T. / Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. In: Ophthalmology. 2005 ; Vol. 112, No. 12. pp. 2088-2094.
@article{2ec7428c333c4a649f87fa90341df8c3,
title = "Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy",
abstract = "Purpose: To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC). Design: Noncomparative, nonrandomized, retrospective interventional case series. Participants: Nine eyes of 9 symptomatic patients with acute focal retinal pigment epithelial leaks secondary to CSC, confirmed with fluorescein angiography, evaluated at 1 of 3 referral retina practices. Methods: Patients were treated with photodynamic therapy using verteporfin. Best-corrected visual acuity (VA) was recorded at presentation and follow-up visits. Main Outcome Measures: Resolution of neurosensory detachment, status of fluorescein leakage, and VA. Results: Neurosensory detachment and fluorescein leakage resolved in all patients within 1 month. Visual acuity improved from 1 to 6 lines in 7 eyes and remained unchanged in 2. At 6 months, there was a statistically significant improvement in mean VA (P = 0.012, Wilcoxon signed ranks test), and mean VA improved from 20/80 to 20/40. No patient lost vision or suffered any treatment-related complications. Conclusion: The treatment of acute CSC with photodynamic therapy may result in prompt resolution of neurosensory detachment and fluorescein leakage, which can be associated with rapidly improved vision. Although this case series is limited in follow-up and number of patients, the encouraging results and lack of visually significant complications suggest that further investigation is warranted.",
author = "Ober, {Michael D.} and Yannuzzi, {Lawrence A.} and Do, {Diana V.} and Spaide, {Richard F.} and Bressler, {Neil M.} and Jampol, {Lee M.} and Allison Angelilli and Eandi, {Chiara M.} and Lyon, {Alice T.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/j.ophtha.2005.06.026",
language = "English (US)",
volume = "112",
pages = "2088--2094",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy

AU - Ober, Michael D.

AU - Yannuzzi, Lawrence A.

AU - Do, Diana V.

AU - Spaide, Richard F.

AU - Bressler, Neil M.

AU - Jampol, Lee M.

AU - Angelilli, Allison

AU - Eandi, Chiara M.

AU - Lyon, Alice T.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Purpose: To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC). Design: Noncomparative, nonrandomized, retrospective interventional case series. Participants: Nine eyes of 9 symptomatic patients with acute focal retinal pigment epithelial leaks secondary to CSC, confirmed with fluorescein angiography, evaluated at 1 of 3 referral retina practices. Methods: Patients were treated with photodynamic therapy using verteporfin. Best-corrected visual acuity (VA) was recorded at presentation and follow-up visits. Main Outcome Measures: Resolution of neurosensory detachment, status of fluorescein leakage, and VA. Results: Neurosensory detachment and fluorescein leakage resolved in all patients within 1 month. Visual acuity improved from 1 to 6 lines in 7 eyes and remained unchanged in 2. At 6 months, there was a statistically significant improvement in mean VA (P = 0.012, Wilcoxon signed ranks test), and mean VA improved from 20/80 to 20/40. No patient lost vision or suffered any treatment-related complications. Conclusion: The treatment of acute CSC with photodynamic therapy may result in prompt resolution of neurosensory detachment and fluorescein leakage, which can be associated with rapidly improved vision. Although this case series is limited in follow-up and number of patients, the encouraging results and lack of visually significant complications suggest that further investigation is warranted.

AB - Purpose: To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC). Design: Noncomparative, nonrandomized, retrospective interventional case series. Participants: Nine eyes of 9 symptomatic patients with acute focal retinal pigment epithelial leaks secondary to CSC, confirmed with fluorescein angiography, evaluated at 1 of 3 referral retina practices. Methods: Patients were treated with photodynamic therapy using verteporfin. Best-corrected visual acuity (VA) was recorded at presentation and follow-up visits. Main Outcome Measures: Resolution of neurosensory detachment, status of fluorescein leakage, and VA. Results: Neurosensory detachment and fluorescein leakage resolved in all patients within 1 month. Visual acuity improved from 1 to 6 lines in 7 eyes and remained unchanged in 2. At 6 months, there was a statistically significant improvement in mean VA (P = 0.012, Wilcoxon signed ranks test), and mean VA improved from 20/80 to 20/40. No patient lost vision or suffered any treatment-related complications. Conclusion: The treatment of acute CSC with photodynamic therapy may result in prompt resolution of neurosensory detachment and fluorescein leakage, which can be associated with rapidly improved vision. Although this case series is limited in follow-up and number of patients, the encouraging results and lack of visually significant complications suggest that further investigation is warranted.

UR - http://www.scopus.com/inward/record.url?scp=28344440277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28344440277&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2005.06.026

DO - 10.1016/j.ophtha.2005.06.026

M3 - Article

C2 - 16325707

AN - SCOPUS:28344440277

VL - 112

SP - 2088

EP - 2094

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 12

ER -